The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia

Landau, D; London, L; Bandach, I; Segev, Y

Landau, D (reprint author), Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel.; Landau, D (reprint author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.

PLOS ONE, 2018; 13 (5):

Abstract

Objectives Anemia is a known driver for hypoxia inducible factor (HIF) which leads to increased renal erythropoietin (EPO) synthesis. Bone marrow (BM)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索